Last reviewed · How we verify

Standard treatment+Xiyanping injection

Jiangxi Qingfeng Pharmaceutical Co. Ltd. · FDA-approved active Small molecule

Xiyanping injection is a traditional Chinese medicine extract that exerts anti-inflammatory, antiviral, and immunomodulatory effects through multiple pathways.

Xiyanping injection is a traditional Chinese medicine extract that exerts anti-inflammatory, antiviral, and immunomodulatory effects through multiple pathways. Used for Viral infections (adjunctive therapy), Inflammatory conditions (adjunctive therapy), Hand, foot and mouth disease.

At a glance

Generic nameStandard treatment+Xiyanping injection
Also known asantiasthmatic,expectorant,antipyretic + Xiyanping injection
SponsorJiangxi Qingfeng Pharmaceutical Co. Ltd.
Drug classTraditional Chinese medicine extract
ModalitySmall molecule
Therapeutic areaInfectious Disease / Immunology
PhaseFDA-approved

Mechanism of action

Xiyanping is derived from Andrographis paniculata and contains active compounds including andrographolide. It functions by inhibiting inflammatory cytokine production, reducing vascular permeability, and enhancing immune responses. The drug is used as an adjunctive treatment combined with standard therapies to improve clinical outcomes in viral and inflammatory conditions.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: